Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.45 |
| ▸ | EGLN1 | Q9GZT9 | 3/20 | 0.45 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.45 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.45 |
| ▸ | KDM6B | O15054 | 1/20 | 0.43 |
| ▸ | KDM5C | P41229 | 1/20 | 0.43 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.43 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.43 |
| ▸ | PEPD | P12955 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28316038 | 0.98 | LMNA (0.43) | LMNAEGLN1ALKBH5SUCNR1KDM6B | |
| SCHEMBL29165564 | 0.93 | LMNA (0.39) | LMNAEGLN1ALKBH5SUCNR1KDM6B | |
| SCHEMBL285627 | 0.89 | CA4 (0.48) | LMNAPEPDCA4TSHRMEN1 | |
| SCHEMBL1643232 | 0.87 | CA4 (0.46) | PEPDCA4TSHRBLMTDP1 | |
| SCHEMBL27473070 | 0.87 | CA4 (0.46) | PEPDCA4TSHRBLMTDP1 | |
| Glycerin SCHEMBL2967167 | 0.86 | EGLN1 (0.34) | LMNAEGLN1ALKBH5SUCNR1KDM6B | |
| SCHEMBL4637032 | 0.86 | LMNA (0.50) | LMNAFOLH1TSHRMEN1BLM | |
| SCHEMBL18614732 | 0.84 | CAMK2A (0.37) | LMNAEGLN1ALKBH5SUCNR1PEPD | |
| SCHEMBL4957043 | 0.82 | MVD (0.41) | LMNAEGLN1ALKBH5SUCNR1KDM6B | |
| SCHEMBL28457661 | 0.81 | PEPD (0.48) | EGLN1PEPDCA4MAPK1SLC13A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240197863-A1 | LIQUID SIX COMBINED VACCINE COMPOSITION | KM BIOLOGICS CO., LTD. (JP) | 2024-06-20 | — | — | US | claimed |
| EP-4327820-A1 | LIQUID SEXTUPLE VACCINE COMPOSITION | KM Biologics Co., Ltd. (JP) | 2024-02-28 | — | — | EP | claimed |
| CN-117177768-A | Composition of 6 mixed liquid vaccines | KM生物医药股份公司 | 2023-12-05 | — | — | CN | claimed |
| CN-113414167-B | Surfactant, preparation method thereof and ceramic part cleaning method | 北京北方华创微电子装备有限公司 | 2023-08-18 | — | — | CN | claimed |
| WO-2022267916-A1 | SURFACTANT, PREPARATION METHOD THEREFOR, AND METHOD FOR CLEANING CERAMIC PART | 北京北方华创微电子装备有限公司 | 2022-12-29 | — | — | WO | claimed |
| CN-113414167-A | Surfactant, preparation method thereof and ceramic part cleaning method | 北京北方华创微电子装备有限公司 | 2021-09-21 | — | — | CN | claimed |
| US-4557934-A | ALONG WITH A DIOL PYRROLIDONE OR AN AZACYCLOPENTAN-2-ONE | THE PROCTER & GAMBLE COMPANY (US) | 1985-12-10 | — | — | US | claimed |
| US-20240197863-A1 | LIQUID SIX COMBINED VACCINE COMPOSITION | KM BIOLOGICS CO., LTD. (JP) | 2024-06-20 | — | — | US | disclosed |
| US-20240197863-A1 | LIQUID SIX COMBINED VACCINE COMPOSITION | KM BIOLOGICS CO., LTD. (JP) | 2024-06-20 | — | — | US | disclosed |
| EP-4327820-A1 | LIQUID SEXTUPLE VACCINE COMPOSITION | KM Biologics Co., Ltd. (JP) | 2024-02-28 | — | — | EP | disclosed |
| EP-4327820-A1 | LIQUID SEXTUPLE VACCINE COMPOSITION | KM Biologics Co., Ltd. (JP) | 2024-02-28 | — | — | EP | disclosed |
| CN-117177768-A | Composition of 6 mixed liquid vaccines | KM生物医药股份公司 | 2023-12-05 | — | — | CN | disclosed |
| CN-117177768-A | Composition of 6 mixed liquid vaccines | KM生物医药股份公司 | 2023-12-05 | — | — | CN | disclosed |
| EP-0112364-A1 | NOVEL DERIVATIVES OF GUANINE II | Astra Läkemedel Aktiebolag (SE) | 1984-07-04 | — | — | EP | disclosed |
| EP-0103551-A2 | Novel derivatives of guanine | Astra Läkemedel Aktiebolag (SE) | 1984-03-21 | — | — | EP | disclosed |
| EP-0103552-A2 | Novel derivatives of guanine | Astra Läkemedel Aktiebolag (SE) | 1984-03-21 | — | — | EP | disclosed |
| WO-1984000168-A1 | NOVEL DERIVATIVES OF GUANINE II | ASTRA LAEKEMEDEL AB (SE) | 1984-01-19 | — | — | WO | disclosed |
| WO-1984000167-A1 | NOVEL DERIVATIVES OF GUANINE I | ASTRA LAEKEMEDEL AB (SE) | 1984-01-19 | — | — | WO | disclosed |
| EP-0095813-A2 | Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine | THE PROCTER & GAMBLE COMPANY (US) | 1983-12-07 | — | — | EP | disclosed |
| WO-1982002202-A1 | NOVEL DERIVATIVES OF GUANINE | ASTRA LAEKEMEDEL AB (SE) | 1982-07-08 | — | — | WO | disclosed |